What's new

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised

Feb 18, 2025 - 17:06
 0
Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Cimzia, certolizumab p...

Next Article

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Da...

Related Posts

EMEA-003419-PIP01-23

EMEA-003419-PIP01-23

Feb 13, 2025  0

Nilotinib hard capsules 50, 150 and 200 mg product-spec...

Feb 12, 2025  0

EU Implementation Guide (IG) on veterinary medicines pr...

Feb 17, 2025  0